FDA Medical devices recall ·

RayCare 2024A SP4. Oncology Information Systems recall

Recall number
Z-2647-2026
Date
(initiated May 20, 2026)
Company / brand
Raysearch Laboratories Ab
Eugeniavagen 18c, Stockholm, N/A, Sweden
Category
Medical devices › Class II
Classification
Class II
Status
Ongoing
Units affected
3 units
Initiated by
Voluntary: Firm initiated

Read the official FDA notice ↗

Product

RayCare 2024A SP4. Oncology Information Systems.

Why was it recalled?

Beam set delivery note issues in which there is potential data loss if the beam set delivery note is modified simultaneously and/or if a note is updated during a treatment session, the user is not notified of the change.

What should you do?

FDA enforcement reports do not list a consumer remedy. Check the product codes below against what you have; if it matches, stop using it and follow the instructions in the firm's or FDA's official notice, or contact the company. If you have health concerns, contact your healthcare provider.

Product codes & lot numbers

Software Version 8.0.4.60077, UDI 0735000201089120241218, Expiration Date: 2030-01-24.

Distribution

Worldwide - US Nationwide distribution.

What does Class II mean?

Class II means use of or exposure to the product may cause temporary or medically reversible adverse health consequences, or the probability of serious harm is remote.

Source: FDA (medical devices), recall Z-2647-2026. Official notice. Republished from public data; RecallFlag is not affiliated with the FDA.